[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-344482-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-344482-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","biomarkers-of-common-molecular-dysregulation-in-tumor-tissue-and-peritumor-mucosa-in-head-and-neck-scc-insights-into-field-cancerization","Biomarkers of Common Molecular Dysregulation in Tumor Tissue and Peritumor Mucosa in Head and Neck SCC - Insights into Field Cancerization","","Field cancerization is a fundamental paradigm in tumorigenesis, emphasizing that carcinogenesis begins long before clinically detectable lesions and often precedes recognizable premalignant changes. A direct manifestation is molecular dysregulation in peritumoral mucosa, histologically normal-appearing tissue with genetic and epigenetic alterations similar to adjacent tumor. This review synthesizes evidence on shared molecular alterations in HNSCC, evaluating their biomarker potential for defining molecular margins and improving surgical precision through evidence-limited literature.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/biomarkers-of-common-molecular-dysregulation-in-tumor-tissue-and-peritumor-mucosa-in-head-and-neck-scc-insights-into-field-cancerization/344482/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/biomarkers-of-common-molecular-dysregulation-in-tumor-tissue-and-peritumor-mucosa-in-head-and-neck-scc-insights-into-field-cancerization/344482.png","ImageObject",300,407,{"name":42,"@type":43},"Aurelia","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is field cancerization in the context of HNSCC?","Question",{"text":63,"@type":64},"Field cancerization describes carcinogenesis starting before clinically detectable lesions, often preceding premalignant changes, and extending into a biologically altered field beyond the visible tumor mass.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does peritumoral mucosa relate to tumor tissue molecular changes?",{"text":68,"@type":64},"Peritumoral mucosa can look histologically normal while still showing genetic and epigenetic alterations comparable to those of the adjacent tumor.",{"name":70,"@type":61,"acceptedAnswer":71},"Which biomarkers have been reported as showing comparable dysregulation in both tumor and peritumor tissues?",{"text":72,"@type":64},"Reported examples include MDM2, E2F2, CDKN2A/p16, ETS-1, MGMT, and multiple microRNAs such as miR-21, miR-96-5p, and miR-145-5p.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},344482,1790176691,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1099514068365,"https://ap-avatar.wpscdn.com/avatar/10000253d8d9f28188e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1794309523707217728","Review  \nBiomarkers of Common Molecular Dysregulation in Tumor Tissue and Peritumor Mucosa in Head and Neck SCC: Insights into Field Cancerization  \nLyuben Dimitrov 1, Gergana S. Stancheva 2, Silva G. Kyurkchiyan 2, Milena Mitkova 1, Iglika Stancheva 1, Silviya Valcheva 1, Kristina Komitova 1, Silviya Skelina 3, Julian Rangachev 2 and Todor M. Popov 1, *  \nAcademic Editor: Jing Gong  \nReceived: 24 November 2025  \nRevised: 10 January 2026  \nAccepted: 23 January 2026  \nPublished: 25 January 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Department of ENT, Medical University, 1527 Sofia, Bulgaria; liuben97@gmail.com (L.D.)  \n2 Molecular Medicine Center, Medical University, 1000 Sofia, Bulgaria; sggiragosyan@abv.bg (S.G.K.)  \n3 Department of Neurology, Medical University, 1000 Sofia, Bulgaria  \n* [Correspondence: t.popov@medfac.mu-sofia.bg](Correspondence: t.popov@medfac.mu-sofia.bg)  \nAbstract  \nField cancerization is a fundamental paradigm in tumorigenesis, emphasizing that carcinogenesis begins long before the appearance of clinically detectable lesions and often precedes recognizable premalignant changes. A direct manifestation of this process is the molecular dysregulation observed in the peritumoral mucosa—histologically normalappearing tissue that nonetheless exhibits genetic and epigenetic alterations similar to those of the adjacent tumor. This review summarizes current evidence on the molecular alterations shared between tumor tissue and peritumoral mucosa in HNSCC and evaluates their potential as biomarkers for defining molecular margins and improving surgical precision. A literature search was conducted in PubMed using combinations of the keywords“peritumor,” “laryngeal”,“HNSCC,” and “field cancerization.” Studies were included if they directly compared tumor tissue with peritumoral mucosa and, preferably, a third set of distant normal control samples. Only nine studies met the inclusion criteria, highlighting the scarcity of focused research in this area. Reported biomarkers exhibiting comparable dysregulation in both tumor and peritumor tissues include MDM2, E2F2, CDKN2A/p16, ETS-1, MGMT, and multiple microRNAs (e.g., miR-21, miR-96-5p, miR-145-5p) . These molecular signatures demonstrate the presence of a biologically altered field extending beyond histologically defined tumor margins. Peritumoral mucosal dysregulation, as a consequence of field cancerization, underscores the need to redefine surgical margins at the molecular level. The identification and validation of biomarkers reflecting this continuum could enable the establishment of molecular margins—improving risk assessment, reducing local recurrence, and advancing personalized oncologic surgery in HNSCC. Standardizing definitions and sampling protocols for “normal adjacent tissue” remains essential for future translational research.  \nKeywords: field cancerization; peritumoral mucosa; molecular margins; biomarkers; head and neck squamous cell carcinoma; laryngeal carcinoma; microRNA; CDKN2A; MDM2; E2F2  \n1. Introduction  \nField cancerization is a fundamental paradigm in tumorigenesis, emphasizing that carcinogenesis begins long before the appearance of clinically detectable lesions and often precedes recognizable premalignant changes. A direct manifestation of this process is  \nthe molecular dysregulation observed in the peritumoral mucosa—histologically normalappearing tissue that nonetheless exhibits genetic and epigenetic alterations similar to those of the adjacent tumor. This phenomenon highlights that tumorigenesis in head and neck cancers extends beyond the visible tumor mass into a broader, biologically altered field.  \nDespite decades of recognition, comprehensive and up-to-date syntheses addressing the molecular mechanisms underlying peritumoral dysregulation in head and neck squamo","cbCaicghkEtu0Pqu","https://ap.wps.com/l/cbCaicghkEtu0Pqu","pdf",30334412,26,"English","# Abstract\n# Introduction\n# Principles and Definition of Field Cancerization","[{\"question\":\"What is field cancerization in the context of HNSCC?\",\"answer\":\"Field cancerization describes carcinogenesis starting before clinically detectable lesions, often preceding premalignant changes, and extending into a biologically altered field beyond the visible tumor mass.\"},{\"question\":\"How does peritumoral mucosa relate to tumor tissue molecular changes?\",\"answer\":\"Peritumoral mucosa can look histologically normal while still showing genetic and epigenetic alterations comparable to those of the adjacent tumor.\"},{\"question\":\"Which biomarkers have been reported as showing comparable dysregulation in both tumor and peritumor tissues?\",\"answer\":\"Reported examples include MDM2, E2F2, CDKN2A/p16, ETS-1, MGMT, and multiple microRNAs such as miR-21, miR-96-5p, and miR-145-5p.\"}]","Biomarkers of Common Molecular Dysregulation in Tumor Tissue and Peritumor Mucosa in Head and Neck SCC - Insights into Field Cancerization | PDF",1790053995,66,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/061b7e78cd64a442b5d02172aac85e49.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/40d94056e6894f27a0cbc4538429da7d.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9a130c6c64cf361c7d89e48a86820034.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5505d2f967bce7c58ec3770731c1b50e.webp",980,1385]